Targeting rare splicing defects: Antisense oligonucleotides offer a therapeutic strategy in FRDA. [PDF]
Kerkhof LMC, Buijsen RAM.
europepmc +1 more source
Comparative Structural Analysis of Escherichia Coli Cyay at Room and Cryogenic Temperatures Using Macromolecular and Serial Crystallography. [PDF]
Shafiei A +4 more
europepmc +1 more source
Evaluation of Mitochondrial Complex 1 Density with [<sup>18</sup>F]BCPP-EF in a Murine Model and Individuals with Friedreich Ataxia. [PDF]
Chen L +24 more
europepmc +1 more source
Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders. [PDF]
de Oliveira MR.
europepmc +1 more source
Polyphenol-Enriched Fraction from Chestnut Shells as a Source of Bioactive Compounds for Friedreich Ataxia. [PDF]
Squillaci G +5 more
europepmc +1 more source
Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia. [PDF]
Talaverón-Rey M +12 more
europepmc +1 more source
Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. [PDF]
Nguyen HT, Napierala M, Napierala JS.
europepmc +1 more source
The Triple Flexion Response in Friedrich's Ataxia. [PDF]
Saluja A, Sahib A, Yadav V.
europepmc +1 more source
Cross-regulation of [2Fe-2S] cluster synthesis by ferredoxin-2 and frataxin. [PDF]
Want K +9 more
europepmc +1 more source
Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed <i>FXN</i> Gene in Friedreich Ataxia. [PDF]
Fang M +8 more
europepmc +1 more source

